Hypera Pharma

Hypera Pharma is one of the largest and most diversified pharmaceutical companies in Brazil and is present in all relevant segments of the sector. With a leading position in several categories, it offers high quality and safety products, continuously investing in innovation and growing sustainably, so that people live longer and better. Leader in the Consumer Health market, which includes over-the-counter drugs, supplements and vitamins, it has in its portfolio iconic brands such as Benegrip, Buscopan, Engov, Epocler, Estomazil, Neosaldina and Zero-Cal. It operates in Prescription Products, with the Mantecorp Farmasa line, and in dermocosmetics, with the brands Mantecorp Skincare, Simple Organic and Bioage. In Similar and Generic, it has a strong presence with Neo Química. More recently, the Company also began its participation in the Institutional Market, aimed at clinics and hospitals. Headquartered in São Paulo and listed on the Novo Mercado of BM&FBovespa since 2008, Hypera Pharma has a team of more than 3.4 thousand employees. And in 2023, it became part of the Corporate Sustainability Index of the Brazilian stock exchange, which brings together companies with the best ESG (environmental, social, and governance) practices.